Cargando…

Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours

The genes encoding Caspase-9 and DFF45 have both recently been mapped to chromosome region 1p36.2, that is a region alleged to involve one or several tumour suppressor genes in neuroblastoma tumours. This study presents an update contig of the ‘Smallest Region of Overlap of deletions’ in Scandinavia...

Descripción completa

Detalles Bibliográficos
Autores principales: Abel, F, Sjöberg, R-M, Ejeskär, K, Krona, C, Martinsson, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375272/
https://www.ncbi.nlm.nih.gov/pubmed/11870543
http://dx.doi.org/10.1038/sj.bjc.6600111
_version_ 1782154617739542528
author Abel, F
Sjöberg, R-M
Ejeskär, K
Krona, C
Martinsson, T
author_facet Abel, F
Sjöberg, R-M
Ejeskär, K
Krona, C
Martinsson, T
author_sort Abel, F
collection PubMed
description The genes encoding Caspase-9 and DFF45 have both recently been mapped to chromosome region 1p36.2, that is a region alleged to involve one or several tumour suppressor genes in neuroblastoma tumours. This study presents an update contig of the ‘Smallest Region of Overlap of deletions’ in Scandinavian neuroblastoma tumours and suggests that DFF45 is localized in the region. The genomic organization of the human DFF45 gene, deduced by in-silico comparisons of DNA sequences, is described for the first time in this paper. In the present study 44 primary tumours were screened for mutation by analysis of the genomic sequences of the genes. In two out of the 44 tumours this detected in the DFFA gene one rare allele variant that caused a non-polar to a polar amino acid exchange in a preserved hydrophobic patch of DFF45. One case was hemizygous due to deletion of the more common allele of this polymorphism. Out of 194 normal control alleles only one was found to carry this variant allele, so in respect of it, no healthy control individual out of 97 was homozygous. Moreover, our RT–PCR expression studies showed that DFF45 is preferably expressed in low-stage neuroblastoma tumours and to a lesser degree in high-stage neuroblastomas. We conclude that although coding mutations of Caspase-9 and DFF45 are infrequent in neuroblastoma tumours, our discovery of a rare allele in two neuroblastoma cases should be taken to warrant further studies of the role of DFF45 in neuroblastoma genetics. British Journal of Cancer (2002) 86, 596–604. DOI: 10.1038/sj/bjc/6600111 www.bjcancer.com © 2002 Cancer Research UK
format Text
id pubmed-2375272
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23752722009-09-10 Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours Abel, F Sjöberg, R-M Ejeskär, K Krona, C Martinsson, T Br J Cancer Genetics and Genomics The genes encoding Caspase-9 and DFF45 have both recently been mapped to chromosome region 1p36.2, that is a region alleged to involve one or several tumour suppressor genes in neuroblastoma tumours. This study presents an update contig of the ‘Smallest Region of Overlap of deletions’ in Scandinavian neuroblastoma tumours and suggests that DFF45 is localized in the region. The genomic organization of the human DFF45 gene, deduced by in-silico comparisons of DNA sequences, is described for the first time in this paper. In the present study 44 primary tumours were screened for mutation by analysis of the genomic sequences of the genes. In two out of the 44 tumours this detected in the DFFA gene one rare allele variant that caused a non-polar to a polar amino acid exchange in a preserved hydrophobic patch of DFF45. One case was hemizygous due to deletion of the more common allele of this polymorphism. Out of 194 normal control alleles only one was found to carry this variant allele, so in respect of it, no healthy control individual out of 97 was homozygous. Moreover, our RT–PCR expression studies showed that DFF45 is preferably expressed in low-stage neuroblastoma tumours and to a lesser degree in high-stage neuroblastomas. We conclude that although coding mutations of Caspase-9 and DFF45 are infrequent in neuroblastoma tumours, our discovery of a rare allele in two neuroblastoma cases should be taken to warrant further studies of the role of DFF45 in neuroblastoma genetics. British Journal of Cancer (2002) 86, 596–604. DOI: 10.1038/sj/bjc/6600111 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-02-12 /pmc/articles/PMC2375272/ /pubmed/11870543 http://dx.doi.org/10.1038/sj.bjc.6600111 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Genetics and Genomics
Abel, F
Sjöberg, R-M
Ejeskär, K
Krona, C
Martinsson, T
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
title Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
title_full Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
title_fullStr Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
title_full_unstemmed Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
title_short Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
title_sort analyses of apoptotic regulators casp9 and dffa at 1p36.2, reveal rare allele variants in human neuroblastoma tumours
topic Genetics and Genomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375272/
https://www.ncbi.nlm.nih.gov/pubmed/11870543
http://dx.doi.org/10.1038/sj.bjc.6600111
work_keys_str_mv AT abelf analysesofapoptoticregulatorscasp9anddffaat1p362revealrareallelevariantsinhumanneuroblastomatumours
AT sjobergrm analysesofapoptoticregulatorscasp9anddffaat1p362revealrareallelevariantsinhumanneuroblastomatumours
AT ejeskark analysesofapoptoticregulatorscasp9anddffaat1p362revealrareallelevariantsinhumanneuroblastomatumours
AT kronac analysesofapoptoticregulatorscasp9anddffaat1p362revealrareallelevariantsinhumanneuroblastomatumours
AT martinssont analysesofapoptoticregulatorscasp9anddffaat1p362revealrareallelevariantsinhumanneuroblastomatumours